Technology Commercialization Group (TCG)
  • About Us
    • Our Team
  • Building Markets
    • White Papers
    • Case Studies
  • Strategic Connections
    • White Papers
    • Case Studies
  • Creating Your Team
    • White Papers
    • Case Studies
  • News & Events
  • Contact

TCG Partner Charlie Turner Advises Client, Asklepios BioPharmaceutical, Inc., in Execution of License with AveXis, Inc., for Use of Duplex Vector Technology in SMA Gene Therapy Program

  • June 18, 2015
  • TCG
  • Archives, News

Click “Read more” and then click on the link for the press release:

http://www.businesswire.com/news/home/20150617005099/en/Asklepios-AveXis-Finalize-License#.VYGFK-coF8F

 

 

 

 

 

 

Please Share This
  • Tweet
  • Share
  • Plus one
  • Pin It
  • Share
Categories
  • News
  • Events
  • White Papers
  • Archives
  • TCG Completes Active 1st Quarter with Multiple New Assignments and Completed Transactions
  • TCG Completes Another Active Quarter with Multiple New Assignments and Completed Transactions
tcg med tech
Serving Clients Since 1998
Recent News
  • Entering the Medical Device Market in Japan November 18, 2020
  • TCG MedTechLaunch™ Assessment Tool September 10, 2020
  • Coding, Coverage and Reimbursement for Durable Medical Equipment June 23, 2020
Securing Reimbursement
for Innovative Medical Technology
2019 white paper
Many innovative medical technologies that gain FDA clearance end up as commercial failures because companies are unable to secure reimbursement.
View White Paper (PDF) →
Privacy Policy
Contact Us
8801 Fast Park Dr. Suite 301
Raleigh, NC 27617
USA: +1-919-941-0700

Heidelberg, Germany
Europe: +49-6221-27262

Social: linkedin youtube



Send us a message →
Copyright 2021 Technology CommercializationGroup, LLC | Home | About Us | Building Markets | Strategic Connections | Creating Your Team | News & Events | Contact